Preclincal development of a disease modifying small molecule therapy for Alzheimer diease.

Project Number
EUJPND-BC|MSFHR|GenBC|PARF-Vocadlo-354
Agency/Funding Organization
Brain Canada|Michael Smith Foundation for Health Research|Genome BC|Pacific Alzheimer Research Foundation
Funding Year
2016
View Full Project Details for Preclincal development of a disease modifying small molecule therapy for Alzheimer diease.
Research Categorization
Primary Disease / Condition
Alzheimer's Disease
CADRO
Category C. Translational Research and Clinical Interventions
3. Drug Discovery (small molecules and biologics)
Researcher and Organization
Principal Investigator
Vocadlo, David
Principal Investigator First Name
David
Principal Investigator Last Name
Vocadlo
Awardee Organization
Simon Fraser University
Contact PI Country
Canada
Project Detail
FY Overall Cost
$313,333
Funding Organization
Special Initiative
EU Joint Programme - Neurodegenerative Disease Research - Research Mapping (2016)

You might be interested in other related resources and tools...